(Q45351320)

13 December 2017

title

von Willebrand disease update: diagnostic and treatment dilemmas (English)

1 reference

13 December 2017

P H B Bolton-Maggs

1

1 reference

13 December 2017

D Lillicrap

series ordinal

2

1 reference

13 December 2017

J Goudemand

series ordinal

3

1 reference

13 December 2017

E Berntorp

series ordinal

4

1 reference

13 December 2017

publication date

1 July 2008

1 reference

13 December 2017

1 reference

13 December 2017

volume

14 Suppl 3

1 reference

13 December 2017

page(s)

56-61

1 reference

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Type 2N von Willebrand disease mutations in Brazilian individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854GIn, and the missense mutation Cys2362Phe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Evaluation of an automated screening assay for von Willebrand disease type 2N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Unexpected presentation of type 2N von Willebrand disease in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

The von Willebrand disease prophylaxis network (vWD PN): exploring a treatment concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

Optimizing factor prophylaxis for the haemophilia population: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2008.01713.X

10.1111/J.1365-2516.2008.01713.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference